Buparvaquone is a second-generation hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone.
[1][2] Buparvaquone is indicated for the therapy and prophylaxis of all forms of Theileriosis
[3] and found to have an anti-Leishmanial activity.
[4]